Applications of phage peptide libraries for epitope discovery and identification of novel anti-virals

Advances in phage display technology revolutionised our understanding of molecular interactions. The aim of using phage display is to screen a peptide library for the identification of rare ligand-bound variants with enhanced specific interaction. One of the most common challenges in dealing with an...

Full description

Bibliographic Details
Main Author: Hakami, Abdulrahim R.
Format: Thesis (University of Nottingham only)
Language:English
Published: 2017
Subjects:
Online Access:https://eprints.nottingham.ac.uk/40700/
_version_ 1848796119470964736
author Hakami, Abdulrahim R.
author_facet Hakami, Abdulrahim R.
author_sort Hakami, Abdulrahim R.
building Nottingham Research Data Repository
collection Online Access
description Advances in phage display technology revolutionised our understanding of molecular interactions. The aim of using phage display is to screen a peptide library for the identification of rare ligand-bound variants with enhanced specific interaction. One of the most common challenges in dealing with an exhaustive peptide library is the selection of target-unrelated peptides. Here we improved methodical approaches that reduce phage binding to the substrate surrounding the target protein. With this we were able to improve the quality of peptide interactions selected from phage libraries. The main purpose of this study is investigate the range of applications of phage-displayed peptide libraries in the context of identifying peptides that interact with virus proteins and antibodies. Using our refined methods, we were able to select inhibitory peptides to Hepatitis C Virus (HCV) that blockade its entry into the host, along with mapping antigenic determinants of several monoclonal antibodies such as anti non-primate hepacivirus (NPHV) antibodies and human HC33.4 anti-HCV antibody. Epitope mapping proved easier than discovering potent viral therapeutics. However, lead sequences were identified that neutralise HCV entry in in vitro models. The presence of thousands of HCV quasispecies leads to another difficulty of discovering pangenotypic inhibitors. Robust alignment and significant binding were demonstrated with peptides selected with both NPHV and HC33.4 human antibodies, while the selection failed with other target proteins. There might be no hot spot residues presented in the libraries used against these proteins. Future investigations should focus on developing the suggested HCV-selected peptides to enhance their affinity. All in all, phage display technology has been successfully developed to improve the performance of peptide libraries in a way that can avoid undesirable sequences during library sorting and enhancing the chance to find favourable ligands.
first_indexed 2025-11-14T19:42:55Z
format Thesis (University of Nottingham only)
id nottingham-40700
institution University of Nottingham Malaysia Campus
institution_category Local University
language English
last_indexed 2025-11-14T19:42:55Z
publishDate 2017
recordtype eprints
repository_type Digital Repository
spelling nottingham-407002025-02-28T13:41:36Z https://eprints.nottingham.ac.uk/40700/ Applications of phage peptide libraries for epitope discovery and identification of novel anti-virals Hakami, Abdulrahim R. Advances in phage display technology revolutionised our understanding of molecular interactions. The aim of using phage display is to screen a peptide library for the identification of rare ligand-bound variants with enhanced specific interaction. One of the most common challenges in dealing with an exhaustive peptide library is the selection of target-unrelated peptides. Here we improved methodical approaches that reduce phage binding to the substrate surrounding the target protein. With this we were able to improve the quality of peptide interactions selected from phage libraries. The main purpose of this study is investigate the range of applications of phage-displayed peptide libraries in the context of identifying peptides that interact with virus proteins and antibodies. Using our refined methods, we were able to select inhibitory peptides to Hepatitis C Virus (HCV) that blockade its entry into the host, along with mapping antigenic determinants of several monoclonal antibodies such as anti non-primate hepacivirus (NPHV) antibodies and human HC33.4 anti-HCV antibody. Epitope mapping proved easier than discovering potent viral therapeutics. However, lead sequences were identified that neutralise HCV entry in in vitro models. The presence of thousands of HCV quasispecies leads to another difficulty of discovering pangenotypic inhibitors. Robust alignment and significant binding were demonstrated with peptides selected with both NPHV and HC33.4 human antibodies, while the selection failed with other target proteins. There might be no hot spot residues presented in the libraries used against these proteins. Future investigations should focus on developing the suggested HCV-selected peptides to enhance their affinity. All in all, phage display technology has been successfully developed to improve the performance of peptide libraries in a way that can avoid undesirable sequences during library sorting and enhancing the chance to find favourable ligands. 2017-03-15 Thesis (University of Nottingham only) NonPeerReviewed application/pdf en arr https://eprints.nottingham.ac.uk/40700/1/Abdu%27s%20Thesis%20-corrected-January%202017.pdf Hakami, Abdulrahim R. (2017) Applications of phage peptide libraries for epitope discovery and identification of novel anti-virals. PhD thesis, University of Nottingham. Anti-virals biopanning hepatitis C virus epitope phage display
spellingShingle Anti-virals
biopanning
hepatitis C virus
epitope
phage display
Hakami, Abdulrahim R.
Applications of phage peptide libraries for epitope discovery and identification of novel anti-virals
title Applications of phage peptide libraries for epitope discovery and identification of novel anti-virals
title_full Applications of phage peptide libraries for epitope discovery and identification of novel anti-virals
title_fullStr Applications of phage peptide libraries for epitope discovery and identification of novel anti-virals
title_full_unstemmed Applications of phage peptide libraries for epitope discovery and identification of novel anti-virals
title_short Applications of phage peptide libraries for epitope discovery and identification of novel anti-virals
title_sort applications of phage peptide libraries for epitope discovery and identification of novel anti-virals
topic Anti-virals
biopanning
hepatitis C virus
epitope
phage display
url https://eprints.nottingham.ac.uk/40700/